Boundless Bio, Inc. (BOLD) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2023: -$46.85M2024: -$60.84M2025: -$46.66M-$46.66M
2023Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$46.66M+23.3%
2024-$60.84M-29.8%
2023-$46.85M